Blocking the ERK-DAPK signaling pathway with the ERK inhibitor SL327 or the antiseizure drug CBZ alleviated seizure-induced exacerbation of AD-like neuropathology in 5×FAD mice. Here, DAPK1 is linked to Alzheimer disease.